Innongem 1gm Injection
Marketer
BDR Pharmaceuticals Internationals Pvt
Salt Composition
Gemcitabine (1gm)
Overview Innongem 1gm Injection
Innongem 1gm Injection treats several cancers, including non-small cell lung, breast, pancreatic, bladder, and ovarian cancers. Administration is solely by a healthcare professional via injection. Dosage and frequency are determined individually by your physician based on your specific condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include nausea, vomiting, anorexia, alopecia, and thrombocytopenia. The medication can suppress blood cell production, increasing infection risk. Regular blood tests monitoring blood cell counts, along with heart, liver, and uric acid levels, are crucial. Inform your doctor about pre-existing heart, liver, or kidney conditions, or any concurrent infection treatments before commencing therapy. Significant drug interactions are possible; disclose all medications to your doctor. This injection is contraindicated during pregnancy and breastfeeding. Reliable contraception for both partners is essential throughout treatment to prevent conception.
Uses of Innongem 1gm Injection
Lung cancer (non-small cell type), breast cancer, pancreatic cancer, bladder cancer, and ovarian cancer.
Major Benefits of Innongem 1gm Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Innongem 1gm Injection:
- Nausea
- Vomiting
- Loss of appetite
- Hair loss
- Low blood platelets
- Allergic reaction
- Breathlessness
- Decreased white blood cell count
- Increased liver enzymes
- Anemia (low number of red blood cells)
- Flu-like symptoms
- Blood in urine
- Skin rash
- Protein in urine
How to use Innongem 1gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Innongem 1gm Injection works:
Innongem 1gm Injection halts cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of essential molecular components, thereby inhibiting cancerous growth and replication.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Innongem 1gm Injection and alcohol may result in significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Innongem 1gm Injection to pregnant individuals poses a confirmed risk to the fetus, precluding its routine use. In exceptional, life-threatening circumstances, a physician might deem its use necessary when potential benefits outweigh known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Innongem 1gm Injection while breastfeeding is contraindicated. Evidence indicates potential infant harm from the medication.
DrivingUNSAFE
Administering Innongem 1gm Injection may induce drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Innongem 1gm Injection's use in individuals with renal impairment. Physician consultation is necessary. Pre-treatment and ongoing kidney function assessment is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Innongem 1gm Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Innongem 1gm Injection :
NA
Facts to Know About Innongem 1gm Injection
| Label | Value |
|---|---|
| Pharmaceutical Category | Pyrimidine Nucleoside Analog |
| Potential for Dependence | None. |
| Type of Medication | Cancer-fighting drugs |
| Mechanism of Action | Metabolic inhibitors |
3,018 People bought this recently